<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
    <channel><atom:link href="http://www.dsm.com/en_US/foodandbeverages/public/home/pages/components/Press_releases.rss" rel="self" type="application/rss+xml" /><title>Press releases in Food &amp; Beverages</title><link>http://www.dsm.com</link><description>Press releases in Food &amp; Beverages</description><language>en</language> 
				 <item><title>Landmark NEI vision study supports important role of FloraGLO® Lutein and OPTISHARP® Zeaxanthin in reducing risk of progression to advanced AMD</title>http://www.dsm.com/en_US/foodandbeverages/public/home/pages/press-releases/2013-05-06-landmark-nei-vision-study-supports-important-role-of-floraglo-lutein-and-optisharp-zeaxanthin.jsp?WT.rss=Press_releases&amp;WT.rss_a=Landmark&#43;NEI&#43;vision&#43;study&#43;supports&#43;important&#43;role&#43;of&#43;FloraGLO%c2%ae&#43;Lutein&#43;and&#43;OPTISHARP%c2%ae&#43;Zeaxanthin&#43;in&#43;reducing&#43;risk&#43;of&#43;progression&#43;to&#43;advanced&#43;AMD&amp;WT.rss_ev=a<guid isPermaLink="false">http://www.dsm.com/en_US/foodandbeverages/public/home/pages/press-releases/2013-05-06-landmark-nei-vision-study-supports-important-role-of-floraglo-lutein-and-optisharp-zeaxanthin.jsp</guid> <pubDate>Mon, 06 May 2013 10:15:00 +0200</pubDate><description>Age-related eye disease study 2 (AREDS2) is the largest trial to date testing the effectiveness of lutein and zeaxanthin in adults with AMD</description></item> <item><title>New study links Lutein, Zeaxanthin and Omega-3 supplementation with eye health benefits</title>http://www.dsm.com/en_US/foodandbeverages/public/home/pages/press-releases/2013-05-03-new-study-links-lutein-zeaxanthin-and-omega-3-supplementation-with-eye-health-benefits.jsp?WT.rss=Press_releases&amp;WT.rss_a=New&#43;study&#43;links&#43;Lutein%2c&#43;Zeaxanthin&#43;and&#43;Omega-3&#43;supplementation&#43;with&#43;eye&#43;health&#43;benefits&amp;WT.rss_ev=a<guid isPermaLink="false">http://www.dsm.com/en_US/foodandbeverages/public/home/pages/press-releases/2013-05-03-new-study-links-lutein-zeaxanthin-and-omega-3-supplementation-with-eye-health-benefits.jsp</guid> <pubDate>Fri, 03 May 2013 10:15:00 +0200</pubDate><description>DSM and Kemin welcome the results of the latest trial to indicate that the nutritional intake of lutein, zeaxanthin and omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs) may be beneficial for patients affected by age-related macular degeneration (AMD). The LUTEGA study, published in JAMA Ophthalmology , demonstrates that supplementation with a combination of lutein, zeaxanthin, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) can result in increased concentrations of lutein, zeaxanthin and fatty acids in plasma and a significant improvement in the optical density of the macular pigment.</description></item> <item><title>DSM and Republic of Tatarstan sign MOU for fortified nutrition</title>http://www.dsm.com/en_US/foodandbeverages/public/home/pages/press-releases/2013-04-08-dsm-and-republic-of-tatarstan-sign-mou-for-fortified-nutrition.jsp?WT.rss=Press_releases&amp;WT.rss_a=DSM&#43;and&#43;Republic&#43;of&#43;Tatarstan&#43;sign&#43;MOU&#43;for&#43;fortified&#43;nutrition&amp;WT.rss_ev=a<guid isPermaLink="false">http://www.dsm.com/en_US/foodandbeverages/public/home/pages/press-releases/2013-04-08-dsm-and-republic-of-tatarstan-sign-mou-for-fortified-nutrition.jsp</guid> <pubDate>Mon, 08 Apr 2013 06:15:00 +0200</pubDate><description>Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed a Memorandum of Understanding (MOU) for a strategic partnership with the Ministry of Health Care of the Republic of Tatarstan with the aim of modernizing the Republic’s public health sector through fortified nutrition. The MOU was signed today in Amsterdam (Netherlands) in the presence of President Vladimir Putin of the Russian Federation and Prime Minister Mark Rutte of the Netherlands.</description></item></channel>
</rss>
